Phase3 Study to Evaluate the Efficacy and Safety of AlbuminInterferon in Combination With Ribavirin Compared With Peginterferon in Combination With Ribavirin in Interferon Alfa Naive Subjects With CHC Genotype 2/3
Latest Information Update: 18 Jul 2023
At a glance
- Drugs Albinterferon alfa 2B (Primary) ; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms ACHIEVE-2/3
- Sponsors Human Genome Sciences
- 05 Jun 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
- 03 Jul 2012 Planned number of patients changed from 920 to 928 as reported by European Clinical Trials Database.
- 29 Aug 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry).